Physician profile
Adam Jonathan Kaye
NPI 1013064096
$132,588.32
in general payments reported to CMS, 2019-2025
5 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $21K · 2021: $24K · 2022: $18K · 2023: $22K · 2024: $26K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $32K · Consulting Fee: $19K · Travel and Lodging: $8,522 · Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $31,635.51 |
| Consulting Fee | $18,811.20 |
| Travel and Lodging | $8,521.52 |
| Food and Beverage | $452.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $116,372.79 | 2019-2025 | Ribfix Blu Advantage, Advantagerib, Ribfix Titan |
| Atricure, INC. | $16,024.46 | 2019-2021 | |
| Depuy Synthes Sales INC. | $138.94 | 2021-2025 | Matrixrib |
| Polynovo North America LLC | $35.55 | 2023 | |
| Kls-Martin L.P. | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kaye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.